Search results for: Competition
Filter search results
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
…and distort the markets to which they are applied by affecting competition, (4) European priority review vouchers (PRVs) are a possible alternative to transferable IP extensions and theoretically could have…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
…Regulatory Policy Institute (RPI) Annual Conference, which explored the trade-offs between complexity and simplicity in competition and regulatory policy. He participated in a session with George Yarrow, Chairman of the…
New Seminar Briefing: Is Pharmaceutical R&D Experiencing a Productivity Crisis?
14 June 2012
…of larger teams with a greater range of expertise A mix of regulatory requirements and marketing changes are making competition tougher, increasing the likelihood that projects will be discontinued The…
Register Now for the OHE Conference on Drug Development in 2022
2 July 2012
…will affect productivity; how collaboration and competition stimulate learning and commercialisation; and the changing roles of large and small biopharmaceutical companies, academia, governments, and payers. The conference will consider specific…
In Memoriam: George Teeling Smith, OHE’s First Director
17 February 2013
…How much competition existed in pharmaceutical markets The economic benefits to the UK of pharmaceutical, NHS and academic research Through OHE, George helped to increase the interest in and understanding…
OHE Welcomes Professors Rawlins and Smith to its Policy Board
6 May 2013
…has acted in numerous governmental advisory capacities, including as a board member of the Audit Commission, and, currently, on the Monitor’s Cooperation and Competition Panel. He also has advised several…
OHE at HESG: Informal Caregiving and Valuing End-of-Life Care
28 June 2013
…actual index?” She also was a discussant for “Patients’ choice and hospital quality competition: Unintended impacts of the signals”, a paper co-authored by Tommaso Gabrieli (University of Reading), Mireia Jofre-Bonet (City…
Personalised Medicine: Economic Incentives for Evidence Generation
28 October 2013
…needed evidence at an acceptable cost and encourage the competition that can lead to “better and more efficient” tests. Creating a positive economic environment, then, is an important component of…
OHE Welcomes Charlesworth and Mays to its Editorial Board
14 January 2014
…and Health Care Research Unit Advisory Group. Anita was a member of OHE’s 2011-12 Commission on Competition in the NHS. Nicholas Mays is a Professor of Health Policy at the…